Search research articles
Contact Us
Filters
Showing results (71-80 of 80) with videos related to
Page
of 8
Sort By:
You have reached the last page of results.
This site can display upto 80 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 20, 1999
Tumor, normal tissue, and plasma pharmacokinetic studies of fluorouracil biomodulation with N-phosphonacetyl-L-aspartate, folinic acid, and interferon alfa
R J Harte, J C Matthews, S M O'Reilly, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
July 1, 1996
Active minimisation of radiation scatter during breast radiotherapy: management implications for young patients with good-prognosis primary neoplasms
R J Epstein, S A Kelly, M Cook, et al.
Physics in Medicine and Biology
|
October 22, 2010
Development and validation of a variance model for dynamic PET: uses in fitting kinetic data and optimizing the injected activity
M D Walker, J C Matthews, M-C Asselin, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
July 24, 2010
Efficacy and tolerability of limited field radiotherapy with concurrent capecitabine in locally advanced pancreatic cancer
A S N Jackson, P Jain, G R Watkins, et al.
British Journal of Cancer
|
December 21, 2006
Hypoxia-inducible factor-1alpha expression in the gastric carcinogenesis sequence and its prognostic role in gastric and gastro-oesophageal adenocarcinomas
E A Griffiths, S A Pritchard, H R Valentine, et al.
Cancer Research
|
June 1, 1997
Studies on the metabolism of the novel antitumor agent [N-methyl-11C]N-[2-(dimethylamino)ethyl]acridine-4-carboxamide in rats and humans prior to phase I clinical trials
S Osman, S K Luthra, F Brady, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 7, 2001
Pharmacokinetic evaluation of N-[2-(dimethylamino)ethyl]acridine-4-carboxamide in patients by positron emission tomography
A Saleem, R J Harte, J C Matthews, et al.
Cancer Research
|
April 18, 2001
Comparative biodistribution and metabolism of carbon-11-labeled N-[2-(dimethylamino)ethyl]acridine-4-carboxamide and DNA-intercalating analogues
S Osman, G Rowlinson-Busza, S K Luthra, et al.
British Journal of Cancer
|
July 1, 2010
The hypoxia-selective cytotoxin NLCQ-1 (NSC 709257) controls metastatic disease when used as an adjuvant to radiotherapy
S J Lunt, C Cawthorne, M Ali, et al.
Structural Dynamics (Melville, N.Y.)
|
September 28, 2019
Electrostatic subframing and compressive-sensing video in transmission electron microscopy
B W Reed, A A Moghadam, R S Bloom, et al.
Page
of 8
Search research articles
Search
Showing results (71-80 of 80) with videos related to
Sort By:
Page
of 8
You have reached the last page of results.
This site can display upto 80 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 20, 1999
Tumor, normal tissue, and plasma pharmacokinetic studies of fluorouracil biomodulation with N-phosphonacetyl-L-aspartate, folinic acid, and interferon alfa
R J Harte, J C Matthews, S M O'Reilly, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
July 1, 1996
Active minimisation of radiation scatter during breast radiotherapy: management implications for young patients with good-prognosis primary neoplasms
R J Epstein, S A Kelly, M Cook, et al.
Physics in Medicine and Biology
|
October 22, 2010
Development and validation of a variance model for dynamic PET: uses in fitting kinetic data and optimizing the injected activity
M D Walker, J C Matthews, M-C Asselin, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
July 24, 2010
Efficacy and tolerability of limited field radiotherapy with concurrent capecitabine in locally advanced pancreatic cancer
A S N Jackson, P Jain, G R Watkins, et al.
British Journal of Cancer
|
December 21, 2006
Hypoxia-inducible factor-1alpha expression in the gastric carcinogenesis sequence and its prognostic role in gastric and gastro-oesophageal adenocarcinomas
E A Griffiths, S A Pritchard, H R Valentine, et al.
Cancer Research
|
June 1, 1997
Studies on the metabolism of the novel antitumor agent [N-methyl-11C]N-[2-(dimethylamino)ethyl]acridine-4-carboxamide in rats and humans prior to phase I clinical trials
S Osman, S K Luthra, F Brady, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 7, 2001
Pharmacokinetic evaluation of N-[2-(dimethylamino)ethyl]acridine-4-carboxamide in patients by positron emission tomography
A Saleem, R J Harte, J C Matthews, et al.
Cancer Research
|
April 18, 2001
Comparative biodistribution and metabolism of carbon-11-labeled N-[2-(dimethylamino)ethyl]acridine-4-carboxamide and DNA-intercalating analogues
S Osman, G Rowlinson-Busza, S K Luthra, et al.
British Journal of Cancer
|
July 1, 2010
The hypoxia-selective cytotoxin NLCQ-1 (NSC 709257) controls metastatic disease when used as an adjuvant to radiotherapy
S J Lunt, C Cawthorne, M Ali, et al.
Structural Dynamics (Melville, N.Y.)
|
September 28, 2019
Electrostatic subframing and compressive-sensing video in transmission electron microscopy
B W Reed, A A Moghadam, R S Bloom, et al.
Page
of 8